As big pharma interest grows in bioelectronics medicine, Astellas swoops in for a startup developing wireless, grain-sized devices powered by ultrasound for CNS disease monitoring and intervention.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Soft ferroelectret ultrasound receiver for targeted peripheral neuromodulation
Nature Communications Open Access 16 December 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Patch, K. Neural dust swept up in latest leap for bioelectronic medicine. Nat Biotechnol 39, 255–256 (2021). https://doi.org/10.1038/s41587-021-00856-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-021-00856-0
This article is cited by
-
Soft ferroelectret ultrasound receiver for targeted peripheral neuromodulation
Nature Communications (2023)